Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
3
50%
Ph not_applicable
2
33%
Ph phase_3
1
17%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 43 (50.0%)
N/A2 (33.3%)

Trials by Status

not_yet_recruiting117%
recruiting117%
enrolling_by_invitation117%
completed350%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DRUG
Total Trials
6